Funding

 

National Institutes of Mental Health (NIMH)

Selective M1 mAChR allosteric modulators for the treatment of schizophrenia (RO1)

National Institutes of Drug Abuse (NIDA)

 Partial antagonists of mGluR5 for the treatment of cocaine addiction (RO1)

Molecular Libraries Program (MLPCN/NIH)

Vanderbilt Specialized Chemistry Center for Accelerated Probe Development (U54)

Michael J. Fox Foundation

Seaside Therapeutics

Collaborative Drug Discovery - Fragile X Syndrome)

Alzheimer’s Association (IIRG)

American Cancer Society (IIRG)

AMGEN

Eisai